title: Detection of patients with hypertrophic cardiomyopathy at risk for paroxysmal atrial fibrillation during sinus rhythm by P-wave dispersion.
abstract: BACKGROUND
  Paroxysmal atrial fibrillation (PAF) in hypertrophic cardiomyopathy (HCM) is associated with poor prognosis. Previous studies have shown good correlation between P-wave dispersion (Pd) and occurrence of PAF. However, Pd in patients with HCM for predicting PAF has not been studied.
  
  
  OBJECTIVE
  The aim of the study was to determine whether Pd could identify patients with HCM who are likely to suffer from PAF.
  
  
  METHODS
  Twenty-two patients with HCM with a history of PAF (Group 1) and 26 patients with HCM without a history of PAF (Group 2) were studied. Maximum (Pmax) and minimum (Pmin) P-wave durations, as well as P-wave dispersion (Pd = Pmax - Pmin) were calculated from 12-lead surface electrocardiograms (ECG).
  
  
  RESULTS
  P-wave dispersion was significantly different between the groups (Group 1: 55 +/- 6 ms vs. Group 2: 37 +/- 8 ms; p<0.001), while Pmax (Group 1: 134 +/- 11 ms vs. Group 2: 128 +/- 13 ms; p = 0.06) and Pmin (Group 1: 78 +/- 9 ms vs. Group 2: 81 +/- 7 ms; p = 0.07) was not significantly different. Patients with a history of PAF had higher left atrial diameter than the patients without PAF (Group 1: 52 +/- 8 mm vs. Group 2: 48 +/- 10 mm; p = 0.02). A cut-off value of 46 ms for Pd had a sensitivity of 76% and a specificity of 82% in discriminating between patients with and without PAF.
  
  
  CONCLUSIONS
  This study suggests that P-wave dispersion could identify patients with HCM who are likely to develop PAF.
authors.affiliation: Gülhane Military Medical Academy, Department of Cardiology, Ankara, Turkey.
authors.forename: Sedat
authors.initials: S
authors.lastname: Köse
authors.forename: Kudret
authors.initials: K
authors.lastname: Aytemir
authors.forename: Elif
authors.initials: E
authors.lastname: Sade
authors.forename: Ilknur
authors.initials: I
authors.lastname: Can
authors.forename: Necla
authors.initials: N
authors.lastname: Ozer
authors.forename: Basri
authors.initials: B
authors.lastname: Amasyali
authors.forename: Serdar
authors.initials: S
authors.lastname: Aksöyek
authors.forename: Kenan
authors.initials: K
authors.lastname: Ovünç
authors.forename: Ferhan
authors.initials: F
authors.lastname: Ozmen
authors.forename: Enver
authors.initials: E
authors.lastname: Atalar
authors.forename: Ersoy
authors.initials: E
authors.lastname: Işik
authors.forename: Sirri
authors.initials: S
authors.lastname: Kes
authors.forename: Ertan
authors.initials: E
authors.lastname: Demirtaş
authors.forename: Ali
authors.initials: A
authors.lastname: Oto
mesh_terms: D000328:Adult; D001281:Atrial Fibrillation / Q000175:diagnosis* / Q000453:epidemiology*; D002312:Cardiomyopathy, Hypertrophic / Q000175:diagnosis* / Q000453:epidemiology*; D004452:Echocardiography; D004562:Electrocardiography; D005260:Female; D006325:Heart Atria / Q000000981:diagnostic imaging / Q000473:pathology / Q000503:physiopathology; D006329:Heart Conduction System / Q000473:pathology* / Q000503:physiopathology; D006352:Heart Ventricles / Q000000981:diagnostic imaging / Q000473:pathology / Q000503:physiopathology; D006801:Humans; D017379:Hypertrophy, Left Ventricular / Q000175:diagnosis / Q000453:epidemiology; D008297:Male; D008875:Middle Aged; D008944:Mitral Valve Insufficiency / Q000175:diagnosis / Q000453:epidemiology; D015999:Multivariate Analysis; D011237:Predictive Value of Tests; D012189:Retrospective Studies; D012307:Risk Factors; D012680:Sensitivity and Specificity; D012720:Severity of Illness Index; D013223:Statistics as Topic; D013318:Stroke Volume / Q000502:physiology